Showing results (141-150 of 324) with videos related to
Sort By:
Pageof 33
Blood Advances|January 4, 2018
ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic modelColin F Greineder, Ian H Johnston, Carlos H Villa, et al.Nature Immunology|March 14, 2007
A structural basis for complement inhibition by Staphylococcus aureusMichal Hammel, Georgia Sfyroera, Daniel Ricklin, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2017
Structural Implications for the Formation and Function of the Complement Effector Protein iC3bMalvina Papanastasiou, Sophia Koutsogiannaki, Yiannis Sarigiannis, et al.Blood|December 17, 2013
Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrinDouglas B Cines, Tatiana Lebedeva, Chandrasekaran Nagaswami, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|November 2, 2010
Red blood cell-coupled tissue plasminogen activator prevents impairment of cerebral vasodilatory responses through inhibition of c-Jun-N-terminal kinase and potentiation of p38 mitogen-activated protein kinase after cerebral photothrombosis in the newborn pigWilliam M Armstead, Kumkum Ganguly, John Riley, et al.American Journal of Respiratory and Critical Care Medicine|April 4, 2009
Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammationBi-Sen Ding, Nankang Hong, Melpo Christofidou-Solomidou, et al.Journal of Thrombosis and Haemostasis : JTH|February 11, 2025
Structural and functional changes underlying activation of monocytes in heparin-induced thrombocytopeniaIzabella Andrianova, Vincent Hayes, Rustem I Litvinov, et al.Blood|August 12, 2004
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopeniaLubica Rauova, Mortimer Poncz, Steven E McKenzie, et al.Immunobiology|June 30, 2016
From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stageDimitrios C Mastellos, Edimara S Reis, Despina Yancopoulou, et al.Journal of Molecular Recognition : JMR|August 7, 2009
Structure-kinetic relationship analysis of the therapeutic complement inhibitor compstatinPaola Magotti, Daniel Ricklin, Hongchang Qu, et al.Pageof 33